Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression

Journal of Hepatology

Volumn 38, Issue 3, 2003, Pages 298-306

  Wong, Nathalie ^a   Chan, Andrew ^a   Lee, Siu Wah ^a   Lam, Ellan ^a   To, Ka Fai ^a   Lai, Paul B S ^a   Li, Xiao Nan ^b   Liew, Choong Tsek ^a   Johnson, Philip J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

1q21 q22; Gene expression; Hepatocellular carcinoma; Interphase fluorescent in situ hybridization

Indexed keywords

AMPLICON; APOPTOSIS; ARTICLE; CALCIUM BINDING; CELL CYCLE; CHROMOSOME 1Q; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA SEQUENCE; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INTERPHASE; LIVER; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YEAST ARTIFICIAL CHROMOSOME;

EID: 0037335209     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00412-9     Document Type: Article

References (30)

1. Waterhouse JAH, Muir CS, CoRrea P, Powell J, editors. Cancer incidence in five continents, vol. IV. Lyon: IARC Scientific Publications, 1982 IARC Scientific Publications, No. 42.
2. Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, editors. Neoplasm of the liver, London: Springer Verlag, 1987. pp. 3-19.
3. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997;18:59-65.
4. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999;154:37-43.
5. Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL, Zhou XD, et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 1999;59:5662-5665.
6. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000;119:431-440.
7. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2000;29:110-116.
8. Wong N, Lai P, Pang E, Fung LF, Sheng Z, Wong V, et al. Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res 2000;6:4000-4009.
9. Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 1999;29:1208-1214.
10. Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, et al. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997;57:481-487.
11. Petersen S, Aninat-Meyer M, Schluns K, Gellert K, Dietel M, Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 2000;82:65-73.
12. Kudoh K, Takano M, Koshikawa T, Hirai M, Yoshida S, Mano Y, et al. Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients. Clin Cancer Res 1999;5:2526-2531.
13. Hirai M, Yoshida S, Kashiwagi H, Kawamura T, Ishikawa T, Kaneko M, et al. 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment. Genes Chromosomes Cancer 1999;25:261-269.
14. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, et al. DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 1999;84:114-121.
15. Cole CG, Goodfellow PN, Bobrow M, Bentley DR. Generation of novel sequence tagged sites (STSs) from discrete chromosomal regions using Alu-PCR. Genomics 1991;10:816-826.
16. Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, et al. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 2000;31:169-178.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 1987;162:156-159.
18. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000;25:144-146.
19. Collins C, Volik S, Kowbel D, Ginzinger D, Ylstra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo WL, Alberts A, Gray JW. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001;11:1034-1042.
20. Wu G, Sinclair C, Hinson S, Ingle JN, Roche PC, Couch FJ. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. Cancer Res 2001;61:4951-4955.
21. Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson Jr. H, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 2002;62:2625-2629.
22. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994;54:4299-4303.
23. Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager LH, Dahlberg AB, et al. Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genet Cytogenet 2001;125:100-111.
24. Willis TG, Zalcberg IR, Coignet LJ, Wlodarska I, Stul M, Jadayel DM, et al. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 1998;91:1873-1881.
25. Hatakeyama S, Osawa M, Omine M, Ishikawa F. JTB: a novel membrane protein gene at 1q21 rearranged in a jumping translocation. Oncogene 1999;18:2085-2090.
26. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 2001;20:6322-6330.
27. Huebner K, Kastury K, Druck T, Salcini AE, Lanfrancone L, Pelicci G, et al. Chromosome locations of genes encoding human signal transduction adapter proteins, Nck (NCK), Shc (SHC1), and Grb2 (GRB2). Genomics 1994;22:281-287.
28. Chow VT, Quek HH. Alpha coat protein COPA (HEP-COP): presence of an Alu repeat in cDNA and identity of the amino terminus to xenin. Ann Hum Genet 1997;61:369-373.
29. Quek HH, Chow VT. Genomic organization and mapping of the human HEP-COP gene (COPA) to 1q. Cytogenet Cell Genet 1997;76:139-143.
30. Roobol A, Holmes FE, Hayes NV, Baines AJ, Carden MJ. Cytoplasmic chaperonin complexes enter neurites developing in vitro and differ in subunit composition within single cells. J Cell Sci 1995;108:1477-1488.